Where to buy Temsirolimus

Temsirolimus (Temsirolimus) is used to treat advanced renal cell carcinoma (RCC, a cancer that starts in the kidney). It can also be used to treat relapsed or refractory mantle cell lymphoma (MCL) in the EU and other places. Temsirolimus belongs to the kinase inhibitor class of drugs, which prevents cancer cells from multiplying by blocking the activity of abnormal proteins, which may help slow tumor growth.

Temsirolimus is a solution (liquid) that can be given by infusion (slow injection into a vein) over 30 to 60 minutes, usually by a doctor or nurse in a doctor's office or infusion center. Temsirolimus may be given once weekly. Patients may develop symptoms such as hives, rash, itching, difficulty breathing or swallowing, facial swelling, flushing, or chest pain during treatment with temsirolimus. If these symptoms occur during treatment with temsirolimus, tell your doctor or other healthcare provider. Your doctor may prescribe other medications to help prevent or relieve these symptoms. Other medications may be prescribed before the patient receives each dose of temsirolimus.

The original drug of temsirolimus has not yet been launched in China, so it cannot be included in domestic medical insurance. Domestic patients cannot yet purchase this drug through relevant domestic channels. The original temsirolimus drug marketed overseas has a Turkish version and a European version. The ingredients of the two are basically the same. The price of each box of 30mg/1.2mL may be more than 10,000 yuan, and the price of 25mg/mL may be around 3,000 yuan per box (the price may fluctuate due to exchange rates). There is currently no generic version of temsirolimus available on the market. For more drug information and specific prices, please consult a medical consultant.